v3.25.3
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (2,705,150) $ (9,934,113)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,914,095 799,591
Allowance for uncollected receivables 30,000 30,000
Write off of deferred financing fees 1,427,729
Change in fair value of warrant liabilities (424,177) (1,395,838)
Gain on debt extinguishment (3,959,054) (1,847,992)
Stock based compensation, including the issuance of restricted shares 498,440 1,262,090
Non-cash interest expense 86,042
Reduction in right of use asset 87,120
Changes in operating assets and liabilities:    
Prepaid expense and other current assets (877,247) (793,008)
Accounts receivable (8,112) (20,000)
Accounts payable 600,842 3,591,279
Accrued expenses (336,925) (1,730,320)
Deferred revenue (2,290)
Operating lease liability (143,008)
Net cash used in operating activities (5,237,134) (8,612,872)
Cash flows from investing activities:    
Purchase of property and equipment (26,316)
Capitalized internal-use software costs (141,512) (73,414)
Net cash used in investing activities (141,512) (99,730)
Cash flows from financing activities:    
Cash and cash equivalents acquired in connection with the reverse recapitalization 858,292
Proceeds from the sale of common stock 2,654,513 8,518,750
Proceeds received from option and warrant exercises 1,549,550 20,264
Payment of financing costs (858,292)
Proceeds from short term loans 1,102,866
Repayment of short term loans (57,200)
Payment of related party note (80,000)
Net cash provided by financing activities 5,249,729 8,459,014
Net decrease in cash and cash equivalents (128,917) (253,588)
Cash and cash equivalents at the beginning of the period 149,273 1,685,013
Cash and cash equivalents at the end of the period 20,356 1,431,425
Supplemental Non-Cash Information    
Settlement of accounts payable and debt into common shares 322,008
Issuance of common stock pursuant to Reseller Agreement 13,475,000
Settlement of accounts payable into convertible note 1,900,000
Financing costs in accrued expenses 200,000
Issuance of common stock for Standby Equity Purchase Agreement liability 432,482
Stock-based compensation capitalized as part of capitalized software costs 5,325 205,154
Settlement of liabilities into common shares 265,494
Conversion of convertible notes into common shares $ 380,000